Merck (MRK)
Add to Watchlists Create an AlertMerck Enterprise Value:
147.92B for May 23, 2013Merck Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 23, 2013 | 147.92B |
| May 22, 2013 | 147.92B |
| May 21, 2013 | 149.79B |
| May 20, 2013 | 143.39B |
| May 17, 2013 | 145.74B |
| May 16, 2013 | 146.89B |
| May 15, 2013 | 147.98B |
| May 14, 2013 | 147.74B |
| May 13, 2013 | 146.29B |
| May 10, 2013 | 145.62B |
| May 9, 2013 | 144.23B |
| May 8, 2013 | 142.72B |
| May 7, 2013 | 143.57B |
| May 6, 2013 | 142.69B |
| May 3, 2013 | 144.78B |
| May 2, 2013 | 144.96B |
| May 1, 2013 | 144.84B |
| April 30, 2013 | 148.79B |
| April 29, 2013 | 151.16B |
| April 26, 2013 | 151.31B |
| April 25, 2013 | 149.74B |
| April 24, 2013 | 151.55B |
| April 23, 2013 | 153.61B |
| April 22, 2013 | 151.46B |
| April 19, 2013 | 150.17B |
| April 18, 2013 | 147.36B |
| April 17, 2013 | 147.96B |
| April 16, 2013 | 148.57B |
| April 15, 2013 | 147.06B |
| April 12, 2013 | 149.02B |
| April 11, 2013 | 149.32B |
| April 10, 2013 | 148.20B |
| April 9, 2013 | 144.19B |
| April 8, 2013 | 144.10B |
| April 5, 2013 | 143.05B |
| April 4, 2013 | 143.62B |
| April 3, 2013 | 143.74B |
| April 2, 2013 | 142.38B |
| April 1, 2013 | 140.69B |
| March 28, 2013 | 140.46B |
| March 27, 2013 | 140.16B |
| March 26, 2013 | 141.03B |
| March 25, 2013 | 138.92B |
| March 22, 2013 | 139.55B |
| March 21, 2013 | 139.22B |
| March 20, 2013 | 140.22B |
| March 19, 2013 | 138.95B |
| March 18, 2013 | 138.74B |
| March 15, 2013 | 140.13B |
| March 14, 2013 | 140.67B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
MRK Enterprise Value Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | 242.70B |
| Pfizer | 215.85B |
| Eli Lilly and Company | 62.60B |
MRK Enterprise Value Rankings
| Overall |
99th percentile 45 of 8006 |
| Sector |
99th percentile 6 of 686 in Healthcare |
| Industry |
89th percentile 6 of 55 in Drug Manufacturers - Major |
MRK Enterprise Value Range, Past 5 Years
| Minimum | 37.30B | Mar 9 2009 |
| Maximum | 153.61B | Apr 23 2013 |
| Average | 103.86B |
